Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.
Brammer JE, Braunstein Z, Katapadi A, Porter K, Biersmith M, Guha A, Vasu S, Yildiz VO, Smith SA, Buck B, Haddad D, Gumina R, William BM, Penza S, Saad A, Denlinger N, Vallakati A, Baliga R, Benza R, Binkley P, Wei L, Mocarski M, Devine SM, Jaglowski S, Addison D.
Brammer JE, et al. Among authors: vallakati a.
J Immunother Cancer. 2021 Aug;9(8):e002303. doi: 10.1136/jitc-2020-002303.
J Immunother Cancer. 2021.
PMID: 34429331
Free PMC article.